Historique de carrière de Fabrice Piu
Anciens postes connus de Fabrice Piu
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| OTONOMY | Directeur Technique/Scientifique/R&D | 01/08/2008 | 01/01/2023 |
| ACADIA PHARMACEUTICALS INC. | Corporate Officer/Principal | - | - |
Formation de Fabrice Piu
| École Normale Supérieure | Doctorate Degree |
| University of Lyon | Graduate Degree |
Statistiques
Internationale
| Etats-Unis | 3 |
| France | 3 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 1 |
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ACADIA PHARMACEUTICALS INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Otonomy, Inc.
 Otonomy, Inc. BiotechnologyHealth Technology Otonomy, Inc. operates as a biopharmaceutical company. engages in the development of therapeutics for neurotology. The firm’s product pipeline includes OTIVIDEX (dexamethasone) Meniere's disease, OTIPRIO (ciprofloxacin otic suspension) acute otitis media with tubes (AOMT), OTO-313 (gacyclidine) tinnitus, OTO-413 (BDNF) hidden hearing Loss, OTO-510 (otoprotectant) prevent CIHL, OTO-6XX (hair cell regeneration) severe hearing loss. It operates under the Otiprio brand. The company was founded by Jay B. Lichter, Jeffrey Harris, Rick Friedman, and Allen F. Ryan on May 6, 2008 and is headquartered in San Diego, CA. | Health Technology |
- Bourse
- Insiders
- Fabrice Piu
- Expérience
